Drug design for induction of antigen-specific immune tolerance

研究成果: ジャーナルへの寄稿学術誌査読

抄録

Allergies and autoimmune diseases caused by the breakdown of immune tolerance to harmless foreign antigens and self-antigens have been attracting attention in recent years as the number of patients increases. The development of antigen-specific immunotherapy for complete cure of allergies and autoimmune diseases, which artificially induces immune tolerance to antigens, has been studied. Immune tolerance therapy requires efficient and specific delivery of antigens to target immune cells, followed by induction of immune cells into a tolerogenic phenotype or anergy. In this process, drugs are required to perform three functions:evasion of the immune response to the antigen, targeting of the immune cells, and regulation of the immune cells. In this review, strategies and drug design for inducing antigen-specific immune tolerance are outlined, examples of recent research are presented, and future prospects are discussed.

本文言語英語
ページ(範囲)142-148
ページ数7
ジャーナルDrug Delivery System
37
2
DOI
出版ステータス出版済み - 2022

!!!All Science Journal Classification (ASJC) codes

  • 薬科学

フィンガープリント

「Drug design for induction of antigen-specific immune tolerance」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル